MINI FUTURE LONG - POLE GROU | Real-time Bid/Ask 08:32:28 2024-06-13 EDT | ||
| 1.16 EUR / 1.2 EUR | +3.51% |
|
| Current month | +11.76% | ||
| 1 month | +15.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 1.21 | +6.14% |
| 24-06-12 | 1.14 | -5.79% |
| 24-06-11 | 1.21 | +8.04% |
| 24-06-10 | 1.12 | -0.88% |
| 24-06-07 | 1.13 | -2.59% |
Delayed Quote Börse Stuttgart
Last update June 13, 2024 at 03:54 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Morgan Stanley |
| WKN | MG0H0G |
| ISIN | DE000MG0H0G6 |
| Date issued | 2024-03-20 |
| Strike | 21.76 CHF |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.25 € |
|---|---|
| Lowest since issue | 0.35 € |
| Spread | 0.04 € |
| Spread % | 3.39% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
33.88
EUR
Average target price
25.12
EUR
Spread / Average Target
-25.84%
- Stock Market
- Certificates
- Certificat
